التفاصيل البيبلوغرافية
| العنوان: |
Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections. |
| المؤلفون: |
Santos Laboissiere, Renato, Araújo Buzelin, Marcelo, Balabram, Débora, De Brot, Marina, Buzelin Nunes, Cristiana, Malagoli Rocha, Rafael, Demas Álvares Cabral, Mônica Maria, Gobbi, Helenice, Laboissiere, Renato Santos, Buzelin, Marcelo Araújo, Nunes, Cristiana Buzelin, Rocha, Rafael Malagoli, Cabral, Mônica Maria Demas Álvares |
| المصدر: |
BMC Gastroenterology; 11/4/2015, Vol. 15, p1-9, 9p, 2 Color Photographs, 2 Charts |
| مصطلحات موضوعية: |
CANCER diagnosis, STOMACH cancer, HER2 protein, CLINICAL pathology, TUMOR classification, TRASTUZUMAB, ESOPHAGOGASTRIC junction, ONCOLOGIC surgery, CANCER, CELL receptors, GASTRECTOMY, IMMUNOHISTOCHEMISTRY, IN situ hybridization, STOMACH tumors, RETROSPECTIVE studies |
| مصطلحات جغرافية: |
BRAZIL |
| مستخلص: |
Background: Gastric cancer is usually diagnosed in an advanced stage of disease and treatment options are sparse. Trastuzumab was recently approved for metastatic or locally advanced carcinomas arising in the stomach or in the gastroesophageal junction in patients with HER2-positive tumors. However, data on the frequency of HER2-positive cases among Brazilian patients are limited. Our aim was to characterize HER2 protein and gene status in a series of Brazilian patients with gastric cancer and to evaluate its association with clinicopathological data.Methods: Histological slides from 124 primary gastrectomies were reviewed and their pathological reports were retrieved from the files at a Brazilian university hospital. Automated immunohistochemistry for HER2 was performed on whole-tissue sections from each tumor. HER2-equivocal cases by immunohistochemistry were submitted to automated dual in situ hybridization for gene amplification evaluation. HER2 status was confronted with clinicopathological parameters in order to assess statistically significant associations.Results: Immunohistochemistry analysis revealed that 13/124 cases (10.5 %) were HER2 positive (3+), 10/124 cases (8.1 %) were equivocal (2+) and 101/124 cases (81.4 %) were negative, being 7 cases 1+. None of the equivocal cases showed gene amplification. The overall HER2 positivity rate was 10.5 %. There was an association between HER2 expression and Laurén's intestinal histological subtype (P = 0.048), well to moderately differentiated tumors (P = 0.004) and presence of lymphovascular invasion (P = 0.031). No association was found between HER2 status and tumor topography.Conclusions: Confronted with data published by other authors, the lower percentage of HER2-positive cases found in our series might be partially explained by the lower frequency of tumors arising at the gastroesophageal junction in comparison with distal gastric carcinomas in Brazilian patients. This could also account for the lack of statistically significant association between HER2 status and tumor topography in our study. [ABSTRACT FROM AUTHOR] |
|
Copyright of BMC Gastroenterology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder